Gene Therapy for Neurological Disorders is organized by Hanson Wade and will be held from Dec 10 - 12, 2019 at The Colonnade Hotel, Boston, Massachusetts, United States of America.
Built with the field's thought-leaders from the likes of Pfizer, Biogen, Voyager and Novartis, GTxN is the industry's first and only meeting dedicated to solving your translational drug development challenges enabling you to accelerate the development of your neurological gene therapy candidate.
• Review recent gene therapy clinical successes and failures targeting neurological disorders to identify improvement areas and opportunities to guide your future research
• Discover the latest advances in administration routes and vector engineering to improve delivery success
• Address immunogenicity and the dosage challenges seen with gene therapies to identify the optimal therapeutic window
Join 60 of your peers at this definitive conference over 3 days, 2 interactive workshops, 6 hours of dedicated networking time and 18 expert industry speakers.
Additional details will be posted as soon as information is available.
|Contact No. :||16174554188
|Registration Type||Last Date||Price|
|Gold: Conference plus 2 Workshops - Standard fee||09 Dec,2019||USD 3697.00|
|Silver: Conference plus 1 Workshop - Early fee||09 Dec,2019||USD 3198.00|
|Bronze: Conference Only - Standard fee||09 Dec,2019||USD 2799.00|
|Workshop(s) Only - Standard fee||09 Dec,2019||USD 599.00|
|Registration Type||End Date||Price|
|Gold: Conference plus 2 Workshops - Early fee||13 Sep,2019||USD 3097.00|
|Silver: Conference plus 1 Workshop - Standard fee||13 Sep,2019||USD 2698.00|
|Bronze: Conference Only - Early fee||13 Sep,2019||USD 2099.00|
|Workshop(s) Only - Early fee||13 Sep,2019||USD 599.00|